BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21722372)

  • 1. Understanding multinational companies in public health systems, using a competitive advantage framework.
    Lethbridge J
    Global Health; 2011 Jul; 7():19. PubMed ID: 21722372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Upper Echelons Perceive Porter's Five Forces? Evidence From Strategic Entrepreneurship in China.
    Shi C; Agbaku CA; Zhang F
    Front Psychol; 2021; 12():649574. PubMed ID: 34938221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Porter’s Five Forces Model and generic strategies for vascular surgery: should be stuck in the middle?
    Sumpio BE
    Vascular; 2013 Jun; 21(3):149-56. PubMed ID: 23518839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Porter's generic strategies in ambulatory health care: a comparison of managerial perceptions in two Israeli sick funds.
    Torgovicky R; Goldberg A; Shvarts S; Bar Dayan Y; Onn E; Levi Y; BarDayan Y
    Health Care Manage Rev; 2005; 30(1):17-23. PubMed ID: 15773250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond "medical tourism": Canadian companies marketing medical travel.
    Turner L
    Global Health; 2012 Jun; 8():16. PubMed ID: 22703873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel.
    Turner L
    Global Health; 2011 Oct; 7():40. PubMed ID: 21995598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the industry using Porter's five forces.
    Vet Rec; 2014 Jan; 174 Suppl 1():3-4. PubMed ID: 24470612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The five competitive forces that shape strategy.
    Porter ME
    Harv Bus Rev; 2008 Jan; 86(1):78-93, 137. PubMed ID: 18271320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating an integrated strategic plan.
    DuCoin C; Kuo PC
    Surgery; 2024 Apr; 175(4):1240-1243. PubMed ID: 38049360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Uptake of Big Data in Health Care: Protocol for a Multinational Mixed-Methods Study.
    Wehrens R; Sihag V; Sülz S; van Elten H; van Raaij E; de Bont A; Weggelaar-Jansen AM
    JMIR Res Protoc; 2020 Oct; 9(10):e16779. PubMed ID: 33090113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A framework for increasing the availability of life cycle inventory data based on the role of multinational companies.
    Miah JH; Griffiths A; McNeill R; Halvorson S; Schenker U; Espinoza-Orias N; Morse S; Yang A; Sadhukhan J
    Int J Life Cycle Assess; 2018; 23(9):1744-1760. PubMed ID: 30956413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
    Parker L; Fabbri A; Grundy Q; Mintzes B; Bero L
    BMJ; 2019 Dec; 367():l6694. PubMed ID: 31831471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Performance of Slovak hospitals as related to Porter's generic strategies].
    Hlavacka S; Bacharova L; Rusnakova V; Wagner R
    Bratisl Lek Listy; 2001; 102(2):106-14. PubMed ID: 11396122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occupational health protection in business economics--business plan for health intervention].
    Rydlewska-Liszkowska I
    Med Pr; 2011; 62(5):481-8. PubMed ID: 22312962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the physiotherapy industry: challenges for marketing.
    Sheppard L
    Health Mark Q; 1996; 14(2):35-42. PubMed ID: 10164446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic analysis of health plan conversions: are they in the public interest?
    Beaulieu ND
    Front Health Policy Res; 2004; 7():129-77. PubMed ID: 15612338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using science as a differentiator in a crowded digital mental health market.
    Huberty J; Beatty CC; Yourell J
    Front Digit Health; 2023; 5():1306527. PubMed ID: 38259255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry issues management organizations: creating a global corporate network to undermine public health.
    McDaniel PA; Intinarelli G; Malone RE
    Global Health; 2008 Jan; 4():2. PubMed ID: 18201375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.